Viewing StudyNCT02626338



Ignite Creation Date: 2024-05-06 @ 7:53 AM
Last Modification Date: 2024-10-26 @ 11:53 AM
Study NCT ID: NCT02626338
Status: COMPLETED
Last Update Posted: 2023-12-20
First Post: 2015-11-18

Brief Title: Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With RR AML
Sponsor: Arog Pharmaceuticals Inc
Organization: Arog Pharmaceuticals Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-02
Start Date Type: ACTUAL
Primary Completion Date: 2018-02
Primary Completion Date Type: ACTUAL
Completion Date: 2018-02
Completion Date Type: ACTUAL
First Submit Date: 2015-11-18
First Submit QC Date: December 8 2015
Study First Post Date: 2015-12-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2023-12-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2019-05-06
Disp First Submit QC Date: May 8 2019
Disp First Post Date: 2019-05-14
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2023-12-18
Last Update Post Date: 2023-12-20
Last Update Post Date Type: ACTUAL